Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168913 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mutlay Sayan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer has substantial heterogeneity in clinical outcomes and therapeutic responses, posing challenges in predicting disease progression and tailoring treatment strategies. Recent studies have highlighted the potential prognostic value of evaluating the tumor microenvironment, including the presence of a histologically overt stromal response (HOST-response) characterized by peri-glandular stromal changes and architectural distortions. This retrospective study examined patient records from The Cancer Genome Atlas database to identify genomic alterations associated with the HOST-response in prostate cancer. Among 348 patients who underwent radical prostatectomy, 160 (45.98%) were identified as having a HOST-response. A gene expression analysis revealed 1263 genes with significantly higher expression in patients with a HOST-response. A protein–protein interaction network analysis identified seven hub genes (KIF2C, CENPA, CDC20, UBE2C, ESPL1, KIF23, and PLK1) highly interconnected in the network. A functional enrichment analysis revealed alterations in the cell division, cytoskeletal organization, cytokinesis, and interleukin-16 signaling pathways in patients with a HOST-response, suggesting dysregulated proliferation and inflammation. The distinct molecular signature associated with the HOST-response provides insights into the tumor–stroma interactions driving adverse outcomes and potential targets for tailored therapeutic interventions in this subset of patients with prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
- Department of Statistics, Ankara University, Ankara 06100, Türkiye.
- Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, USA.
- Department of Pathology and Laboratory Medicine, Rutgers University, New Brunswick, NJ 07102, USA.
- Histopathology Department, Harrogate District Hospital, Harrogate HG2 7SX, UK.
- Laboratory of Pathology, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Mutlay Sayan, Yetkin Tuac, Mahmut Akgul, Dilara Akbulut, David D Yang, Cagdas Aktan
Zitieren
APA
Sayan, M., Tuac, Y., Akgul, M., Kucukcolak, S., Tjio, E., Akbulut, D., Chen, L. W., Yang, D. D., Moningi, S., Leeman, J. E., Orio, P. F., Nguyen, P. L., D'Amico, A. V., & Aktan, C. (2024). Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168913
Vancouver
Sayan M, Tuac Y, Akgul M, Kucukcolak S, Tjio E, Akbulut D, et al. Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168913
BibTeX
@article{Sayan2024,
author = {Sayan, Mutlay and Tuac, Yetkin and Akgul, Mahmut and Kucukcolak, Samet and Tjio, Elza and Akbulut, Dilara and Chen, Luke W and Yang, David D and Moningi, Shalini and Leeman, Jonathan E and Orio, Peter F and Nguyen, Paul L and D'Amico, Anthony V and Aktan, Cagdas},
title = {Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168913}
}
EUVIMED